Literature DB >> 12011455

Initiating oncogenic event determines gene-expression patterns of human breast cancer models.

Kartiki V Desai1, Nianqing Xiao, Weili Wang, Lisa Gangi, John Greene, John I Powell, Robert Dickson, Priscilla Furth, Kent Hunter, Raju Kucherlapati, Richard Simon, Edison T Liu, Jeffrey E Green.   

Abstract

Molecular expression profiling of tumors initiated by transgenic overexpression of c-myc, c-neu, c-ha-ras, polyoma middle T antigen (PyMT) or simian virus 40 T/t antigen (T-ag) targeted to the mouse mammary gland have identified both common and oncogene-specific events associated with tumor formation and progression. The tumors shared great similarities in their gene-expression profiles as compared with the normal mammary gland with an induction of cell-cycle regulators, metabolic regulators, zinc finger proteins, and protein tyrosine phosphatases, along with the suppression of some protein tyrosine kinases. Selection and hierarchical clustering of the most variant genes, however, resulted in separating the mouse models into three groups with distinct oncogene-specific patterns of gene expression. Such an identification of targets specified by particular oncogenes may facilitate development of lesion-specific therapeutics and preclinical testing. Moreover, similarities in gene expression between human breast cancers and the mouse models have been identified, thus providing an important component for the validation of transgenic mammary cancer models.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011455      PMCID: PMC124512          DOI: 10.1073/pnas.102172399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  The Myc/Max/Mad network and the transcriptional control of cell behavior.

Authors:  C Grandori; S M Cowley; L P James; R N Eisenman
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 2.  A concise guide to cDNA microarray analysis.

Authors:  P Hegde; R Qi; K Abernathy; C Gay; S Dharap; R Gaspard; J E Hughes; E Snesrud; N Lee; J Quackenbush
Journal:  Biotechniques       Date:  2000-09       Impact factor: 1.993

Review 3.  The Rb/E2F pathway: expanding roles and emerging paradigms.

Authors:  J W Harbour; D C Dean
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

4.  Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chloride.

Authors:  C J Newton; K Eycott; V Green; S L Atkin
Journal:  J Steroid Biochem Mol Biol       Date:  2000-05       Impact factor: 4.292

5.  Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.

Authors:  K Yoshidome; M A Shibata; C Couldrey; K S Korach; J E Green
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 6.  Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond.

Authors:  F J Esteva; V Valero; L Pusztai; L Boehnke-Michaud; A U Buzdar; G N Hortobagyi
Journal:  Oncologist       Date:  2001

7.  Gene-expression profiles in hereditary breast cancer.

Authors:  I Hedenfalk; D Duggan; Y Chen; M Radmacher; M Bittner; R Simon; P Meltzer; B Gusterson; M Esteller; O P Kallioniemi; B Wilfond; A Borg; J Trent; M Raffeld; Z Yakhini; A Ben-Dor; E Dougherty; J Kononen; L Bubendorf; W Fehrle; S Pittaluga; S Gruvberger; N Loman; O Johannsson; H Olsson; G Sauter
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

8.  New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor status.

Authors:  E Jacobs; P C Bulpitt; I G Coutts; J F Robertson
Journal:  Anticancer Drugs       Date:  2000-02       Impact factor: 2.248

9.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

10.  Identification of c-myc responsive genes using rat cDNA microarray.

Authors:  Q M Guo; R L Malek; S Kim; C Chiao; M He; M Ruffy; K Sanka; N H Lee; C V Dang; E T Liu
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

View more
  61 in total

Review 1.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 2.  Statistical issues in the design and analysis of gene expression microarray studies of animal models.

Authors:  Lisa M McShane; Joanna H Shih; Aleksandra M Michalowska
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

3.  Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation.

Authors:  Bing Liu; Lin Liu; Anna Tsykin; Gregory J Goodall; Jeffrey E Green; Min Zhu; Chang Hee Kim; Jiuyong Li
Journal:  Bioinformatics       Date:  2010-10-17       Impact factor: 6.937

4.  Molecular cytogenetics of mouse models of breast cancer.

Authors:  Thomas Ried; Kathy Dorritie; Zoë Weaver; Danny Wangsa; Michael J Difilippantonio; Cristina Montagna
Journal:  Breast Dis       Date:  2004

5.  Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization.

Authors:  Tobias May; Hansjörg Hauser; Dagmar Wirth
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

6.  Growth arrest-inducing genes are activated in Dbl-transformed mouse fibroblasts.

Authors:  Raffaella Melani; Fabio Sallustio; Paolo Fardin; Cristina Vanni; Marzia Ognibene; Catherine Ottaviano; Giovanni Melillo; Luigi Varesio; Alessandra Eva
Journal:  Gene Expr       Date:  2006

7.  PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium.

Authors:  Joëlle Dupont; Jean Pierre Renou; Moshe Shani; Lothar Hennighausen; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.

Authors:  Daniel J Nolan; Alessia Ciarrocchi; Albert S Mellick; Jaspreet S Jaggi; Kathryn Bambino; Sunita Gupta; Emily Heikamp; Michael R McDevitt; David A Scheinberg; Robert Benezra; Vivek Mittal
Journal:  Genes Dev       Date:  2007-06-15       Impact factor: 11.361

Review 9.  Cyclins and breast cancer.

Authors:  Robert L Sutherland; Elizabeth A Musgrove
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 10.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.